Table 2.
PFGE results for some clinical isolates sharing GDCa genotypes
| Name and LSP-MVR typeb | Isolate name | Site | PFGE pattern |
|---|---|---|---|
| GDC1 | |||
| 2112-3383 | 4904 | Montreal, Canada | 10 |
| HMC02 | Seattle | Not interpretable | |
| 108 | Southern California | 11 | |
| W355 | Southern California | 10 | |
| 03240 | Montreal | 13 | |
| GDC7 | |||
| 1221-4282 | W214 | Southern California | 7 |
| HMC08 | Seattle | 7 | |
| HMC24 | Seattle | 4 | |
| W216-8 | Southern California | 5 | |
| 105 | Southern California | 8 |
a
GDCs, geographically dispersed clinical strains. GDCs were defined by the same LSP-MVR type being found for at least one clinical isolate at each of two or more geographical locations.
b
LSP-MVR and PFGE types are given for all members of LSP-MVR-defined GDCs for which archived cultures from more than one location were available for PFGE analysis; identity by PFGE of isolates from distant geographic locations could be tested only for GDC1 and GDC7.